Australia's TGA issues updated guidelines on drug supply chain releases

SINGAPORE--Australia's Therapeutic Goods Administration (TGA) has updated guidance on the release of medicine products from the last manufacturer in the supply chain responsible for certifying the quality before the products are released onto the Australian market. The draft covers all products including investigational drugs, vaccines and biotechnology items, but does not cover active pharmaceutical ingredients. Guidance